Extracellular Membrane Vesicles as Vehicles for Brain Cell-to-Cell Interactions in Physiological as well as Pathological Conditions

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Schiera, Gabriella ^a   Di Liegro, Carlo Maria ^a   Di Liegro, Italia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; PROTEIN; RNA; MICRORNA;

BLOOD BRAIN BARRIER; BRAIN CANCER; BRAIN CELL; BRAIN NERVE CELL; CANCER CELL; CELL COMMUNICATION; CELL FUNCTION; DEGENERATIVE DISEASE; EXOSOME; GLIA CELL; HUMAN; INTRACELLULAR SIGNALING; LONG TERM MEMORY; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; REVIEW; BRAIN; GENETICS; GLIA; MEMBRANE; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; SYNAPSE; TRANSPORT AT THE CELLULAR LEVEL; TRANSPORT VESICLE;

BIOLOGICAL TRANSPORT; BRAIN; EXTRACELLULAR VESICLES; HUMANS; MEMBRANES; MICRORNAS; NEUROGLIA; NEURONAL PLASTICITY; NEURONS; SYNAPSES; TRANSPORT VESICLES;

EID: 84947460163     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/152926     Document Type: Review

References (153)

1. E. Cocucci and J. Meldolesi, "Ectosomes and exosomes: shedding the confusion between extracellular vesicles, " Trends in Cell Biology, vol. 25, no. 6, pp. 364-372, 2015.
2. B. Gyorgy, T. G. Szabo, M. Pasztoi et al., "Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles, " Cellular and Molecular Life Sciences, vol. 68, no. 16, pp. 2667-2688, 2011.
3. T. Kobayashi, M. H. Beuchat, M. Lindsay et al., "Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport, " Nature Cell Biology, vol. 1, no. 2, pp. 113-118, 1999.
4. K. Trajkovic, C. Hsu, S. Chiantia et al., "Ceramide triggers budding of exosome vesicles into multivesicular endosomes, " Science, vol. 319, no. 5867, pp. 1244-1247, 2008.
5. C. Bissig and J. Gruenberg, "ALIX and the multivesicular endosome: ALIX in wonderland, " Trends in Cell Biology, vol. 24, no. 1, pp. 19-25, 2014.
6. J. Kowal, M. Tkach, and C. Thery, "Biogenesis and secretion of exosomes, " Current Opinion in Cell Biology, vol. 29, pp. 116-125, 2014.
7. F. Bianco, C. Perrotta, L. Novellino et al., "Acid sphingomyelinase activity triggers microparticle release from glial cells, " The EMBO Journal, vol. 28, no. 8, pp. 1043-1054, 2009.
8. B. Shen, N. Wu, M. Yang Jr., andS. J. Gould, "Proteintargeting to exosomes/microvesicles by plasmamembrane anchors, " Journal of Biological Chemistry, vol. 286, no. 16, pp. 14383-14395, 2011.
9. J.-M. Yang and S. J. Gould, "The cis-acting signals that target proteins to exosomes and microvesicles, " Biochemical Society Transactions, vol. 41, no. 1, pp. 277-282, 2013.
10. L. M. Mashburn-Warren and M. Whiteley, "Special delivery: vesicle trafficking in prokaryotes, " Molecular Microbiology, vol. 61, no. 4, pp. 839-846, 2006.
11. S. J. Biller, F. Schubotz, S. E. Roggensack, A. W. Thompson, R. E. Summons, and S. W. Chisholm, "Bacterial vesicles in marine ecosystems, " Science, vol. 343, no. 6167, pp. 183-186, 2014.
12. D. Tarin, "Fine structure of murine mammary tumours: the relationship between epithelium and connective tissue in neoplasms induced by various agents, " British Journal of Cancer, vol. 23, no. 2, pp. 417-425, 1969.
13. E. G. Trams, C. J. Lauter, J. Norman Salem, and U. Heine, "Exfoliation of membrane ecto-enzymes in the form of microvesicles, " Biochimica et Biophysica Acta, vol. 645, no. 1, pp. 63-70, 1981.
14. D. D. Taylor, C. G. Taylor, C. G. Jiang, and P. H. Black, "Characterization of plasma membrane shedding from murine melanoma cells, " International Journal of Cancer, vol. 41, no. 4, pp. 629-635, 1988.
15. V. Dolo, A. Ginestra, G. Ghersi, H. Nagase, andM. L. Vittorelli, "Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities, " Journal of Submicroscopic Cytology and Pathology, vol. 26, no. 2, pp. 173-180, 1994.
16. S. D'Agostino, M. Salamone, I. Di Liegro, and M. L. Vittorelli, "Membrane vesicles shed by oligodendroglioma cells induce neuronal apoptosis, " International Journal of Oncology, vol. 29, no. 5, pp. 1075-1085, 2006.
17. I. A. Bab, A. Muhlrad, and J. Sela, "Ultrastructural and biochemical study of extracellular matrix vesicles in normal alveolar bone of rats, " Cell and Tissue Research, vol. 202, no. 1, pp. 1-7, 1979.
18. N. Dainiak, "Surface membrane-associated regulation of cell assembly, differentiation, and growth, " Blood, vol. 78, no. 2, pp. 264-276, 1991.
19. G. Schiera, P. Proia, C. Alberti, M. Mineo, G. Savettieri, and I. Di Liegro, "Neurons produce FGF2 and VEGF and secrete them at least in part by shedding extracellular vesicles, " Journal of Cellular andMolecularMedicine, vol. 11, no. 6, pp. 1384-1394, 2007.
20. P. Proia, G. Schiera, M. Mineo et al., "Astrocytes shed extracellular vesicles that contain fibroblast growth factor-2 and vascular endothelial growth factor, " International Journal of Molecular Medicine, vol. 21, no. 1, pp. 63-67, 2008.
21. J. Faure, G. Lachenal, M. Court et al., "Exosomes are released by cultured cortical neurones, " Molecular and Cellular Neuroscience, vol. 31, no. 4, pp. 642-648, 2006.
22. N. Arraud, R. Linares, S. Tan et al., "Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration, " Journal of Thrombosis and Haemostasis, vol. 12, no. 5, pp. 614-627, 2014.
23. A. Lo Cicero, I. Majkowska, H. Nagase, I. Di Liegro, and L. Troeberg, "Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity, " Matrix Biology, vol. 31, no. 4, pp. 229-233, 2012.
24. C. I. Matei, C. Boulocher, C. Boule et al., "Ultrastructural analysis of healthy synovial fluids in three mammalian species, " Microscopy and Microanalysis, vol. 20, no. 3, pp. 903-911, 2014.
25. T. Chen, Q. Y. Xi, R. S. Ye et al., "Exploration of microRNAs in porcine milk exosomes, " BMC Genomics, vol. 15, article 100, 2014.
26. A. Gallo, M. Tandon, I. Alevizos, and G. G. Illei, "The majority of microRNAs detectable in serumand saliva is concentrated in exosomes, " PLoS ONE, vol. 7, no. 3, Article ID e30679, 2012.
27. Y. Ogawa, Y. Taketomi, M. Murakami, M. Tsujimoto, and R. Yanoshita, "Small RNA transcriptomes of two types of exosomes in humanwhole saliva determined by next generation sequencing, " Biological and Pharmaceutical Bulletin, vol. 36, no. 1, pp. 66-75, 2013.
28. N. J. Abbott, A. A. K. Patabendige, D. E. M. Dolman, S. R. Yusof, and D. J. Begley, "Structure and function of the blood-brain barrier, " Neurobiology of Disease, vol. 37, no. 1, pp. 13-25, 2010.
29. G. Schiera, E. Bono, M. P. Raffa et al., "Synergistic effects of neurons and astrocytes on the differentiation of brain capillary endothelial cells in culture, " Journal of Cellular and Molecular Medicine, vol. 7, no. 2, pp. 165-170, 2003.
30. G. Schiera, S. Sala, A. Gallo et al., "Permeability properties of a three-cell type in vitro model of blood-brain barrier, " Journal of Cellular andMolecularMedicine, vol. 9, no. 2, pp. 373-379, 2005.
31. N. Ferrara and T. Davis-Smyth, "The biology of vascular endothelial growth factor, " Endocrine Reviews, vol. 18, no. 1, pp. 4-25, 1997.
32. A. Bikfalvi, S. Klein, G. Pintucci, and D. B. Rifkin, "Biological roles of fibroblast growth factor-2, " Endocrine Reviews, vol. 18, no. 1, pp. 26-45, 1997.
33. S. Taverna, G. Ghersi, A. Ginestra et al., "Shedding ofmembrane vesicles mediates fibroblast growth factor-2 release from cells, " Journal of Biological Chemistry, vol. 278, no. 51, pp. 51911-51919, 2003.
34. C. Villarroya-Beltri, C. Gutierrez-Vazquez, F. Sanchez-Cabo et al., "Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs, " Nature Communications, vol. 4, article 2980, 2013.
35. A. Tietje, K. N. Maron, Y. Wei, D. M. Feliciano, and G. J. Bouma, "Cerebrospinal fluid extracellular vesicles undergo age dependent declines and contain known and novel non-coding rnas, " PLoS ONE, vol. 9, no. 11, Article ID e113116, 2014.
36. A. R. Taylor, M. B. Robinson, D. J. Gifondorwa, M. Tytell, and C. E. Milligan, "Regulation of heat shock protein 70 release in astrocytes: role of signaling kinases, " Developmental Neurobiology, vol. 67, no. 13, pp. 1815-1829, 2007.
37. G. Schiera, C. M. Di Liegro, P. Saladino et al., "Oligodendroglioma cells synthesize the differentiation-specific linker histone H1 and release it into the extracellular environment through shed vesicles, " International Journal of Oncology, vol. 43, no. 6, pp. 1771-1776, 2013.
38. S. Wang, F. Cesca, G. Loers et al., "Synapsin I is an oligomannose-carrying glycoprotein, acts as an oligomannosebinding lectin, and promotes neurite outgrowth and neuronal survival when released via glia-derived exosomes, " Journal of Neuroscience, vol. 31, no. 20, pp. 7275-7290, 2011.
39. O. Sbai, A. Ould-Yahoui, L. Ferhat et al., "Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes, " Glia, vol. 58, no. 3, pp. 344-366, 2010.
40. G. Lachenal, K. Pernet-Gallay, M. Chivet et al., "Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity, " Molecular and Cellular Neuroscience, vol. 46, no. 2, pp. 409-418, 2011.
41. M. Chivet, F. Hemming, K. Pernet-Gallay, S. Fraboulet, and R. Sadoul, "Emerging role of neuronal exosomes in the central nervous system, " Frontiers in Physiology, vol. 3, article 145, 2012.
42. C. Fruhbeis, D. Frohlich, W. P. Kuo, and E.-M. Kramer-Albers, "Extracellular vesicles as mediators of neuron-glia communication, " Frontiers in Cellular Neuroscience, vol. 7, article 182, 2013.
43. U. Funfschilling, L. M. Supplie, D. Mahad et al., "Glycolytic oligodendrocytesmaintainmyelin and long-termaxonal integrity, " Nature, vol. 485, no. 7399, pp. 517-521, 2012.
44. Y. Lee, B. M. Morrison, Y. Li et al., "Oligodendroglia metabolically support axons and contribute to neurodegeneration, " Nature, vol. 487, no. 7408, pp. 443-448, 2012.
45. E.-M. Kramer-Albers, N. Bretz, S. Tenzer et al., "Oligodendrocytes secrete exosomes containing major myelin and stressprotective proteins: trophic support for axons" Proteomics-Clinical Applications, vol. 1, no. 11, pp. 1446-1461, 2007.
46. J. R. Sotelo, L. Canclini, A. Kun et al., "Myosin-Va-dependent cell-to-cell transfer of RNA from Schwann cells to axons, " PLoS ONE, vol. 8, no. 4, Article ID e61905, 2013.
47. C. Fruhbeis, D. Frohlich, W. P. Kuo et al., "Neurotransmittertriggered transfer of exosomes mediates oligodendrocyteneuron communication, " PLoS Biology, vol. 11, no. 7, Article ID e1001604, 2013.
48. D. Frohlich, W. P. Kuo, C. Fruhbeis et al., "Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation, " Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, vol. 369, no. 1652, 2014.
49. C. M. Di Liegro, G. Schiera, and I. Di Liegro, "Regulation of mRNA transport, localizationand translation in the nervous system of mammals (Review), " International Journal of Molecular Medicine, vol. 33, no. 4, pp. 747-762, 2014.
50. E. Koenig, "Organized ribosome-containing structural domains in axons, " Results and Problems in Cell Differentiation, vol. 48, pp. 173-191, 2009.
51. J. Tcherkezian, P. A. Brittis, F. Thomas, P. P. Roux, and J. G. Flanagan, "Transmembrane receptor DCC associates with protein synthesis machinery and regulates translation, " Cell, vol. 141, no. 4, pp. 632-644, 2010.
52. F. A. Court, W. T. J. Hendriks, H. D. MacGillavry, J. Alvarez, and J. Van Minnen, "Schwann cell to axon transfer of ribosomes: toward a novel understanding of the role of glia in the nervous system, " Journal of Neuroscience, vol. 28, no. 43, pp. 11024-11029, 2008.
53. J. L. Twiss and M. Fainzilber, "Ribosomes in axons-scrounging from the neighbors" Trends in Cell Biology, vol. 19, no. 5, pp. 236-243, 2009.
54. F. A. Court, R. Midha, B. A. Cisterna et al., "Morphological evidence for a transport of ribosomes from Schwann cells to regenerating axons, " Glia, vol. 59, no. 10, pp. 1529-1539, 2011.
55. J. R. Sotelo, L. Canclini, A. Kun et al., "Glia to axon RNA transfer, " Developmental Neurobiology, vol. 74, no. 3, pp. 292-302, 2014.
56. F. Bianco, E. Pravettoni, A. Colombo et al., "Astrocyte-derived ATP induces vesicle shedding and IL-1 release frommicroglia, " Journal of Immunology, vol. 174, no. 11, pp. 7268-7277, 2005.
57. I. Prada, R. Furlan, M. Matteoli, and C. Verderio, "Classical and unconventional pathways of vesicular release in microglia, " Glia, vol. 61, no. 7, pp. 1003-1017, 2013.
58. F. Antonucci, E. Turola, L. Riganti et al., "Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipidmetabolism, " EMBOJournal, vol. 31, no. 5, pp. 1231-1240, 2012.
59. M. Gabrielli, N. Battista, L. Riganti et al., "Active endocannabinoids are secreted on extracellular membrane vesicles, " The EMBO Reports, vol. 16, no. 2, pp. 213-220, 2015.
60. I. Y. Tamboli, E. Barth, L. Christian et al., "Statins promote the degradation of extracellular amyloid beta-peptide by microglia via stimulation of exosome-associated insulindegrading enzyme (IDE) secretion, " The Journal of Biological Chemistry, vol. 285, no. 48, pp. 37405-37414, 2010.
61. A. S. Haqqani, C. E. Delaney, T.-L. Tremblay, C. Sodja, J. K. Sandhu, and D. B. Stanimirovic, "Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells, " Fluids and Barriers of the CNS, vol. 10, no. 1, article 4, 2013.
62. M. Chivet, C. Javalet, K. Laulagnier, B. Blot, F. J. Hemming, and R. Sadoul, "Exosomes secreted by cortical neurons upon glutamatergic synapse activation specifically interact with neurons, " Journal of Extracellular Vesicles, vol. 3, Article ID24722, 2014.
63. G. N. Fuller and B. W. Scheithauer, "The 2007 revised World Health Organization (WHO) classification of tumours of the central nervous system: newly codified entities, " Brain Pathology, vol. 17, no. 3, pp. 304-307, 2007.
64. D. N. Louis, H. Ohgaki, O. D. Wiestler et al., "The 2007WHO classification of tumours of the central nervous system, " Acta Neuropathologica, vol. 114, no. 2, pp. 97-109, 2007.
65. I. Jovcevska, "Glioma and glioblastoma-howmuch dowe (not) know (Review), " Molecular and Clinical Oncology, vol. 1, no. 6, pp. 935-941, 2013.
66. E. C. Burton and M. D. Prados, "Malignant gliomas, " Current Treatment Options in Oncology, vol. 1, no. 5, pp. 459-468, 2000.
67. W. Taal, J. E. Bromberg, andM. J. vandenBent, "Chemotherapy in glioma, " CNS Oncology, vol. 4, no. 3, pp. 179-192, 2015.
68. F. Zhang, C. L. Xu, and C. M. Liu, "Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma, " Drug Design, Development and Therapy, vol. 9, pp. 2089-2100, 2015.
69. L. G. Dubois, L. Campanati, C. Righy et al., "Gliomas and the vascular fragility of the blood brain barrier, " Frontiers in Cellular Neuroscience, vol. 8, article 418, 13 pages, 2014.
70. E. Pap, E. Pallinger, and A. Falus, "The role ofmembrane vesicles in tumorigenesis, " Critical Reviews in Oncology/Hematology, vol. 79, no. 3, pp. 213-223, 2011.
71. K. Al-Nedawi, B. Meehan, J. Micallef et al., "Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells, " Nature Cell Biology, vol. 10, no. 5, pp. 619-624, 2008.
72. R. Nieuwland and A. Sturk, "Why do cells release vesicles" Thrombosis Research, vol. 125, supplement 1, pp. S49-S51, 2010.
73. E. H. Wilson, W. Weninger, and C. A. Hunter, "Trafficking of immune cells in the central nervous system, " Journal of Clinical Investigation, vol. 120, no. 5, pp. 1368-1379, 2010.
74. C. Cossetti, J. A. Smith, N. Iraci, T. Leonardi, C. Alfaro-Cervello, and S. Pluchino, "Extracellular membrane vesicles and immune regulation in the brain, " Frontiers in Physiology, vol. 3, article 117, 2012.
75. R. Fu, Q. Shen, P. Xu, J. J. Luo, and Y. Tang, "Phagocytosis of microglia in the central nervous system diseases, " Molecular Neurobiology, vol. 49, pp. 1422-1434, 2014.
76. T. Wurdinger, K. Deumelandt, H. J. van der Vliet, P. Wesseling, and T. D. de Gruijl, "Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle, " Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, vol. 1846, no. 2, pp. 560-575, 2014.
77. M. Record, C. Subra, S. Silvente-Poirot, and M. Poirot, "Exosomes as intercellular signalosomes and pharmacological effectors, " Biochemical Pharmacology, vol. 81, no. 10, pp. 1171-1182, 2011.
78. E. van der Pol, A. N. Boing, P. Harrison, A. Sturk, and R. Nieuwland, "Classification, functions, and clinical relevance of extracellular vesicles, " Pharmacological Reviews, vol. 64, no. 3, pp. 676-705, 2012.
79. J. S. Rao, "Molecular mechanisms of glioma invasiveness: the role of proteases, " Nature Reviews Cancer, vol. 3, no. 7, pp. 489-501, 2003.
80. A. C. Bellail, S. B. Hunter, D. J. Brat, C. Tan, and E. G. Van Meir, "Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion, " International Journal of Biochemistry and Cell Biology, vol. 36, no. 6, pp. 1046-1069, 2004.
81. A. M. Costa, F. Pinto, O. Martinho, M. J. Oliveira, P. Jordan, and R. M. Reis, "Silencing of the tumor suppressor gene WNK2 is associated with upregulation of MMP2 and JNK in gliomas, " Oncotarget, vol. 6, no. 3, pp. 1422-1434, 2015.
82. P. O. Esteve, P. Tremblay, M. Houde, Y. St-Pierre, and R. Mandeville, "In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators, " Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1403, no. 1, pp. 85-96, 1998.
83. H. Konnecke and I. Bechmann, "The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas, " Clinical and Developmental Immunology, vol. 2013, Article ID914104, 15 pages, 2013.
84. M. C. Papadopoulos and A. S. Verkman, "Aquaporin water channels in the nervous system, " Nature Reviews Neuroscience, vol. 14, no. 4, pp. 265-277, 2013.
85. E. McCoy and H. Sontheimer, "Expression and function of water channels (aquaporins) in migrating malignant astrocytes, " Glia, vol. 55, no. 10, pp. 1034-1043, 2007.
86. S. Noell, R. Ritz, K. Wolburg-Buchholz, H. Wolburg, and P. Fallier-Becker, "An allograft glioma model reveals the dependence of aquaporin-4 expression on the brain microenvironment, " PLoS ONE, vol. 7, Article IDe36555, 2012.
87. G. Fossdal, E. O. Vik-Mo, C. Sandberg et al., "Aqp 9 and brain tumour stemcells, " The ScientificWorld Journal, vol. 2012, Article ID 915176, 9 pages, 2012.
88. E. J. Suero Molina, H. Ardon, J. Schroeteler et al., "Aquaporin-4 in glioma and metastatic tissues harboring 5-aminolevulinic acid-induced porphyrin fluorescence, " Clinical Neurology and Neurosurgery, vol. 115, no. 10, pp. 2075-2081, 2013.
89. S. J. Zhu, K. J. Wang, S. W. Gan, J. Xu, S. Y. Xu, and S. Q. Sun, "Expression of aquaporin8 in human astrocytomas: correlation with pathologic grade, " Biochemical and Biophysical Research Communications, vol. 440, no. 1, pp. 168-172, 2013.
90. J. Li, C. A. Sherman-Baust, M. Tsai-Turton, R. E. Bristow, R. B. Roden, and P. J. Morin, "Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer, " BMC cancer, vol. 9, p. 244, 2009.
91. L. Blanc, J. Liu, M. Vidal, J. A. Chasis, X. An, and N. Mohandas, "The water channel aquaporin-1 partitions into exosomes during reticulocyte maturation: implication for the regulation of cell volume, " Blood, vol. 114, no. 18, pp. 3928-3934, 2009.
92. J. M. Street, W. Birkhoff, R. I. Menzies, D. J. Webb, M. A. Bailey, and J. W. Dear, "Exosomal transmission of functional aquaporin 2 in kidney cortical collecting duct cells, " Journal of Physiology, vol. 589, no. 24, pp. 6119-6127, 2011.
93. M. Noerholm, L. Balaj, T. Limperg et al., "RNAexpression patterns in serum microvesicles from patients with glioblastoma multiforme and controls, " BMC Cancer, vol. 12, article 22, 2012.
94. P. Kucharzewska, H. C. Christianson, J. E. Welch et al., "Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 18, pp. 7312-7317, 2013.
95. K. J. Svensson, P. Kucharzewska, H. C. Christianson et al., "Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 32, pp. 13147-13152, 2011.
96. D. Liang, S. Bhatta, V. Gerzanich, and J. M. Simard, "Cytotoxic edema: mechanisms of pathological cell swelling, " Neurosurgical focus, vol. 22, no. 5, p. E2, 2007.
97. A. Lo Cicero, G. Schiera, P. Proia et al., "Oligodendroglioma cells shed microvesicles which contain TRAIL as well as molecular chaperones and induce cell death in astrocytes, " International Journal of Oncology, vol. 39, no. 6, pp. 1353-1357, 2011.
98. K. E. van der Vos, L. Balaj, J. Skog, and X. O. Breakefield, "Brain tumor microvesicles: insights into intercellular communication in the nervous system, " Cellular and Molecular Neurobiology, vol. 31, no. 6, pp. 949-959, 2011.
99. C. C. Y. Li, S. A. Eaton, P. E. Young et al., "Gliomamicrovesicles carry selectively packaged coding and noncoding RNAs which alter gene expression in recipient cells, " RNA Biology, vol. 10, no. 8, pp. 1333-1344, 2013.
100. L. Balaj, R. Lessard, L. Dai et al., "Tumourmicrovesicles contain retrotransposon elements and amplified oncogene sequences, " Nature Communications, vol. 2, no. 1, p. 180, 2011.
101. T. C. Roberts, K. V. Morris, and M. S. Weinberg, "Perspectives on the mechanism of transcriptional regulation by long noncoding RNAs, " Epigenetics, vol. 9, no. 1, pp. 13-20, 2014.
102. M. Guescini, S. Genedani, V. Stocchi, and L. F. Agnati, "Astrocytes and Glioblastoma cells release exosomes carrying mtDNA, " Journal of Neural Transmission, vol. 117, no. 1, pp. 1-4, 2010.
103. J. Skog, T. Wurdinger, S. van Rijn et al., "Glioblastoma microvesicles transport RNAand proteins that promote tumour growth and provide diagnostic biomarkers, " Nature Cell Biology, vol. 10, no. 12, pp. 1470-1476, 2008.
104. E. D'Asti, D. Garnier, T. H. Lee, L. Montermini, B. Meehan, and J. Rak, "Oncogenic extracellular vesicles in brain tumor progression, " Frontiers in Physiology, vol. 3, article 294, 2012.
105. M. Mizoguchi, Y. Guan, K. Yoshimoto et al., "Clinical implications of microRNAs in human glioblastoma, " Frontiers in Oncology, vol. 3, article 19, Article IDArticle 00019, 2013.
106. S. A. M. Rao, V. Santosh, and K. Somasundaram, "Genomewide expression profiling identifies deregulated miRNAs in malignant astrocytoma, " Modern Pathology, vol. 23, no. 10, pp. 1404-1417, 2010.
107. A. Bronisz, Y. Wang, M. O. Nowicki et al., "Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1, " Cancer Research, vol. 74, no. 3, pp. 738-750, 2014.
108. L. Camacho, P. Guerrero, and D. Marchetti, "MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes, " PLoS ONE, vol. 8, no. 9, Article ID e73790, 2013.
109. D. A. Chistiakov and V. P. Chekhonin, "Extracellular vesicles shed by glioma cells: pathogenic role and clinical value, " Tumor Biology, vol. 35, no. 9, pp. 8425-8438, 2014.
110. F. H. Hochberg, N. A. Atai, D. Gonda et al., "Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science, " Expert Review ofMolecular Diagnostics, vol. 14, no. 4, pp. 439-452, 2014.
111. D. R. Santiago-Dieppa, J. Steinberg, D. Gonda, V. J. Cheung, B. S. Carter, and C. C. Chen, "Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients, " Expert Review of Molecular Diagnostics, vol. 14, no. 7, pp. 819-825, 2014.
112. J. S. Redzic, T. H. Ung, and M. W. Graner, "Glioblastoma extracellular vesicles: reservoirs of potential biomarkers, " Pharmacogenomics and PersonalizedMedicine, vol. 7, no. 1, pp. 65-77, 2014.
113. L. Vannucci, "Stroma as an active player in the development of the tumor microenvironment, " CancerMicroenvironment, 2014.
114. R. Safaei, B. J. Larson, T. C. Cheng et al., "Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drugresistant human ovarian carcinoma cells, " Molecular Cancer Therapeutics, vol. 4, no. 10, pp. 1595-1604, 2005.
115. J. Gong, R. Jaiswal, J.-M. Mathys, V. Combes, G. E. R. Grau, and M. Bebawy, "Microparticles and their emerging role in cancer multidrug resistance, " Cancer Treatment Reviews, vol. 38, no. 3, pp. 226-234, 2012.
116. M. S. Fiandaca, D. Kapogiannis, M. Mapstone et al., "Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study, " Alzheimer's & Dementia, 2014.
117. F. Agosta, D. Dalla Libera, E. G. Spinelli et al., "Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease, " Annals of Neurology, vol. 76, no. 6, pp. 813-825, 2014.
118. H. B. Huttner, D. Corbeil, C. Thirmeyer et al., "Increased membrane shedding-indicated by an elevation of CD133-enriched membrane particles-into the CSF in partial epilepsy, " Epilepsy Research, vol. 99, no. 1-2, pp. 101-106, 2012.
119. D. A. Kanhai, F. L. J. Visseren, Y. van der Graaf et al., "Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease, " International Journal of Cardiology, vol. 168, no. 3, pp. 2358-2363, 2013.
120. D. D. Taylor andC. Gercel-Taylor, "Exosome platformfor diagnosis and monitoring of traumatic brain injury, " Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, vol. 369, no. 1652, Article ID 20130503, 2014.
121. M. Saenz-Cuesta, I. Osorio-Querejeta, and D. Otaegui, "Extracellular vesicles in multiple sclerosis: what are they telling us" Frontiers in Cellular Neuroscience, vol. 8, article 100, 2014.
122. E. Colombo, B. Borgiani, C. Verderio, and R. Furlan, "Microvesicles: novel biomarkers for neurological disorders, " Frontiers in Physiology, vol. 3, article 63, 2012.
123. B. Fevrier, D. Vilette, F. Archer et al., "Cells release prions in association with exosomes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 26, pp. 9683-9688, 2004.
124. P. Saa, O. Yakovleva, J. de Castro et al., "First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification, " The Journal of Biological Chemistry, vol. 289, no. 42, pp. 29247-29260, 2014.
125. B. M. Coleman andA. F. Hill, "Extracellular vesicles-their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases, " Seminars in Cell & Developmental Biology, vol. 40, pp. 89-96, 2015.
126. E. Emmanouilidou, K. Melachroinou, T. Roumeliotis et al., "Cell-produced alpha-synuclein is secreted in a calciumdependent manner by exosomes and impacts neuronal survival, " TheJournal ofNeuroscience, vol. 30, no. 20, pp. 6838-6851, 2010.
127. T. Tsunemi, K. Hamada, and D. Krainc, "ATP13A2/PARK9 regulates secretion of exosomes and-synuclein, " Journal of Neuroscience, vol. 34, no. 46, pp. 15281-15287, 2014.
128. L. Rajendran, M. Honsho, T. R. Zahn et al., "Alzheimer's disease-amyloid peptides are released in association with exosomes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 30, pp. 11172-11177, 2006.
129. V. Vingtdeux, M. Hamdane, A. Loyens et al., "Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies, " The Journal of Biological Chemistry, vol. 282, no. 25, pp. 18197-18205, 2007.
130. M. Merezhko, P. Muggalla, N. Nykanen et al., "Multiplex assay for live-cell monitoring of cellular fates of amyloid-precursor protein (APP), " PLoS ONE, vol. 9, no. 6, Article IDe98619, 2014.
131. R. A. Sharples, L. J. Vella, R. M. Nisbet et al., "Inhibition of-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes, " The FASEB Journal, vol. 22, no. 5, pp. 1469-1478, 2008.
132. M. B. Dinkins, S. Dasgupta, G. Wang, G. Zhu, and E. Bieberich, "Exosome reduction invivo is associated with lower amyloid plaque load in the 5XFADmousemodel of Alzheimer's disease, " Neurobiology of Aging, vol. 35, no. 8, pp. 1792-1800, 2014.
133. P. Joshi, E. Turola, A. Ruiz et al., "Microglia convert aggregated amyloid-into neurotoxic forms through the shedding of microvesicles, " Cell Death and Differentiation, vol. 21, no. 4, pp. 582-593, 2014.
134. M. Chivet, C. Javalet, F. Hemming et al., "Exosomes as a novel way of interneuronal communication, " Biochemical Society Transactions, vol. 41, no. 1, pp. 241-244, 2013.
135. M. Basso, S. Pozzi, M. Tortarolo et al., "Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis, "The Journal of Biological Chemistry, vol. 288, no. 22, pp. 15699-15711, 2013.
136. P. Novak, M. Prcina, and E. Kontsekova, "Tauons and prions: infamous cousins" Journal of Alzheimer's Disease, vol. 26, no. 3, pp. 413-430, 2011.
137. M. E. Kabir and J. G. Safar, "Implications of prion adaptation and evolution paradigm for human neurodegenerative diseases, " Prion, vol. 8, no. 1, pp. 111-116, 2014.
138. K. L. Gendreau and G. F. Hall, "Tangles, toxicity, and tau secretion in AD-new approaches to a vexing problem, " Frontiers in Neurology, vol. 4, article 160, 2013.
139. A. Gomez-Ramos, M. Daz-Hernandez, R. Cuadros, F. Hernandez, and J. Avila, "Extracellular tau is toxic to neuronal cells, " FEBS Letters, vol. 580, no. 20, pp. 4842-4850, 2006.
140. G. F. Hall and S. Saman, "Death or secretion: The demise of a plausible assumption about CSF-tau in alzheimer disease" Communicative and Integrative Biology, vol. 5, no. 6, pp. 623-626, 2012.
141. S. Saman, W. Kim, M. Raya et al., "Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease, " Journal of Biological Chemistry, vol. 287, no. 6, pp. 3842-3849, 2012.
142. N. Bhatia and G. F. Hall, "Untangling the role of tau in Alzheimer's disease: a unifying hypothesis, " Translational Neuroscience, vol. 4, no. 2, pp. 115-133, 2013.
143. J. Avila, D. Simon, M. Daz-Hernandez, J. Pintor, and F. Hernandez, "Sources of extracellular tau and its signaling, " Journal of Alzheimer's Disease, vol. 40, no. 1, pp. S7-S15, 2014.
144. W. Kim, S. Lee, C. Jung, A. Ahmed, G. Lee, and G. F. Hall, "Interneuronal transfer of human tau between lamprey central neurons in situ, " Journal of Alzheimer's Disease, vol. 19, no. 2, pp. 647-664, 2010.
145. M. N. Le, W. Kim, S. Lee, A. C. McKee, andG. F. Hall, "Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model, " American Journal of Neurodegenerative Disease, vol. 1, no. 3, pp. 316-333, 2012.
146. G. Lee, "Tau and src family tyrosine kinases, " Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1739, no. 2-3, pp. 323-330, 2005.
147. A. Poehler, W. Xiang, P. Spitzer et al., "Autophagy modulates SNCA/-synuclein release, thereby generating a hostile microenvironment, " Autophagy, vol. 10, no. 12, pp. 2171-2192, 2015.
148. C. Verderio, L. Muzio, E. Turola et al., "Myeloid microvesicles are a marker and therapeutic target for neuroinflammation, " Annals of Neurology, vol. 72, no. 4, pp. 610-624, 2012.
149. L. J. Vella, D. L. V. Greenwood, R. Cappai, J.-P. Y. Scheerlinck, and A. F. Hill, "Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid, " Veterinary Immunology and Immunopathology, vol. 124, no. 3-4, pp. 385-393, 2008.
150. D. Chiasserini, J. R. T. van Weering, S. R. Piersma et al., "Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset, " Journal of Proteomics, vol. 106, pp. 191-204, 2014.
151. H. Arai, M. Terajima, M. Miura et al., "Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease, " Annals of Neurology, vol. 38, no. 4, pp. 649-652, 1995.
152. G. V. W. Johnson, P. Seubert, T. M. Cox, R. Motter, J. P. Brown, and D. Galasko, "The protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments, " Journal of Neurochemistry, vol. 68, no. 1, pp. 430-433, 1997.
153. J. M. Street, P. E. Barran, C. L. Mackay et al., "Identification and proteomic profiling of exosomes in human cerebrospinal fluid, " Journal of Translational Medicine, vol. 10, no. 1, article 5, 2012.